US OptionsDetailed Quotes
KZIA240719C5000
- 0.05
- -0.05-50.00%
15min DelayClose Jul 12 15:52 ET
0.05High0.05Low
0.05Open0.10Pre Close42 Volume383 Open Interest5.00Strike Price210.00Turnover786.95%IV464.25%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1494Delta0.2390Gamma17.92Leverage Ratio-0.0155Theta0.0000Rho2.68Eff Leverage0.0003Vega
Kazia Therapeutics Stock Discussion
The $Dow Jones Industrial Average(.DJI.US)$surged to a new record, closing up 247.15 points (0.62%) at 40,000.90. The $S&P 500 Index(.SPX.US)$ and $Nasdaq Composite Index(.IXIC.US)$ also saw gains of 0.55% and 0.63% respectively. This rally was driven by positive investor sentiment despite mixed economic signals.
Key Stock Movements
• eVTOL Stocks: $Joby Aviation(JOBY.US)$ soared nearly 28% and $Archer Aviation(ACHR.US)$ rose over...
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, has recently announced findings from a Phase II/III clinical trial evaluating their novel drug, paxalisib, for the treatment of glioblastoma. Glioblastoma is a highly aggressive and life-threatening brain cancer, representing one of th...
No comment yet